Breast Cancer Clinical Trial
Trial of Myocet in Metastatic Breast Cancer
Summary
The purpose of the study is to examine the safety and effectiveness of the drug combination of Myocet, paclitaxel and trastuzumab compared to paclitaxel and trastuzumab without Myocet, as first line treatment for patients with metastatic HER2+ breast cancer.
Eligibility Criteria
Inclusion Criteria:
Metastatic Her2+ Breast cancer by FISH analysis
No prior chemotherapy for metastatic disease
Measurable disease
normal left ventricular ejection fraction
Exclusion Criteria:
prior doxorubicin treatment exceeding 300 mg/m2 or epirubicin exceeding 600 mg/m2
relapse within 12 months of completion of adjuvant trastuzumab, taxane or anthracycline therapy
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 28 Locations for this study
San Diego California, 92121, United States
Aurora Colorado, 80045, United States
Coral Springs Florida, 33065, United States
Kissimmee Florida, 34741, United States
Plantation Florida, 33324, United States
Columbus Georgia, 31904, United States
Skokie Illinois, 60076, United States
Hutchinson Kansas, 67502, United States
Cumberland Maryland, 21502, United States
Greenville North Carolina, 27834, United States
Canton Ohio, 44710, United States
Columbus Ohio, 43235, United States
Bethlehem Pennsylvania, 18015, United States
Dunmore Pennsylvania, 18512, United States
Philadelphia Pennsylvania, 19106, United States
Columbia South Carolina, 29203, United States
Sioux Falls South Dakota, 57104, United States
Knoxville Tennessee, 37920, United States
Buenos Aires , , Argentina
Buenos Aires , , Argentina
Buenos Aires , , Argentina
Buenos Aires , , Argentina
Buenos Aires , , Argentina
Neuquen , , Argentina
Santa Fe , , Argentina
Santa Fe , , Argentina
Santa Fe , , Argentina
Villa Dominico , , Argentina
Moncton New Brunswick, E1C 8, Canada
Halifax Nova Scotia, B3H 1, Canada
London Ontario, N6A 4, Canada
Ottawa Ontario, K1H 8, Canada
Toronto Ontario, M5G 2, Canada
Montreal Quebec, H2L 4, Canada
Montreal Quebec, H2W 1, Canada
Regina Saskatchewan, S47 7, Canada
Saskatoon Saskatchewan, S7N 4, Canada
Quebec , G1S 4, Canada
Berlin , , Germany
Magdeburg , , Germany
Mannheim , , Germany
München , , Germany
Offenbach , , Germany
Tübingen , , Germany
Wiesbaden , , Germany
Asarwa Gujarat, , India
Bangalore , , India
Bangalore , , India
Chennai , , India
Hyderabaad , , India
Jaipur , , India
Kerala , , India
Kolkata , , India
Kolkata , , India
Maharashtra , , India
Maharashtra , , India
Mangalore , , India
Mumbai , , India
New Delhi , , India
New Delhi , , India
New Delhi , , India
Noida , , India
Catanzaro , , Italy
Chieti , , Italy
Genova , , Italy
Palermo , , Italy
Pavia , , Italy
Roma , , Italy
Rozzano , , Italy
Gdańsk , , Poland
Gliwice , , Poland
Lublin , , Poland
Olsztyn , , Poland
Tarnow , , Poland
Warszawa , , Poland
Warszawa , , Poland
Zielona Gora , , Poland
Åódź , , Poland
Åšwidnica , , Poland
Lisbon , , Portugal
Moscow , , Russian Federation
Moscow , , Russian Federation
Moscow , , Russian Federation
Ryazan , , Russian Federation
Sochi , , Russian Federation
St Petersberg , , Russian Federation
St Petersberg , , Russian Federation
St. Petersberg , , Russian Federation
St. Petersburg , , Russian Federation
Yaroslavl , , Russian Federation
Barcelona , , Spain
Barcelona , , Spain
Lleida , , Spain
Madrid , , Spain
Palma de Mallorca , , Spain
Salamanca , , Spain
Sevilla , , Spain
Terrassa , , Spain
Valencia , , Spain
Valencia , , Spain
Zaragoza , , Spain
Broomfield , , United Kingdom
Cardiff , , United Kingdom
London , , United Kingdom
London , , United Kingdom
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.